APA (7th ed.) Citation

Chen, Z., Yang, X., Chen, Z., Li, M., Wang, W., Yang, R., . . . Zeng, G. (2023). A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy. BMC Medicine, 21(1), 1. https://doi.org/10.1186/s12916-023-03094-0

Chicago Style (17th ed.) Citation

Chen, Zude, et al. "A New Histone Deacetylase Inhibitor Remodels the Tumor Microenvironment by Deletion of Polymorphonuclear Myeloid-derived Suppressor Cells and Sensitizes Prostate Cancer to Immunotherapy." BMC Medicine 21, no. 1 (2023): 1. https://doi.org/10.1186/s12916-023-03094-0.

MLA (9th ed.) Citation

Chen, Zude, et al. "A New Histone Deacetylase Inhibitor Remodels the Tumor Microenvironment by Deletion of Polymorphonuclear Myeloid-derived Suppressor Cells and Sensitizes Prostate Cancer to Immunotherapy." BMC Medicine, vol. 21, no. 1, 2023, p. 1, https://doi.org/10.1186/s12916-023-03094-0.